Stock Events

Hikma Pharmaceuticals (HIK.LSE) Q3 2024 Earnings

8AugConfirmed
Q4 2022
Q2 2023
Q1 2024
Q3 2024
0.91
33.82
66.73
99.63

Details

Expected EPS
N/A
Actual EPS
99.63404
Surprise EPS
99.63
Surprise Percent
+∞%

Description

Hikma Pharmaceuticals (HIK.LSE) has reported earnings of 99.63404 per share for Q3 2024.

0 Comments

Share your thoughts